BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9494586)

  • 1. Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin.
    Eskens FA; Roelofs EJ; Hermus AR; Verhagen CA
    Anticancer Res; 1997; 17(6D):4667-70. PubMed ID: 9494586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasoactive intestinal polypeptide(VIP)- and insulin-producing cells--molecular biology, physiology and pathology].
    Okamoto H
    Nihon Naibunpi Gakkai Zasshi; 1984 Dec; 60(12):1449-63. PubMed ID: 6099284
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic islet cell carcinoma with gastrin and vasoactive intestinal polypeptide production.
    Barragry TP; Wick MR; Delaney JP
    Arch Surg; 1985 Oct; 120(10):1178-81. PubMed ID: 2994597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
    Nasir A; Gardner NM; Strosberg J; Ahmad N; Choi J; Malafa MP; Coppola D; Kwekkeboom DJ; Teunissen JJ; Kvols LK
    Pancreas; 2008 Apr; 36(3):309-13. PubMed ID: 18362846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic vipoma arising from colonic primary tumour.
    Bradley C; Haddock G; Pickard RG; Rankin EM
    Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.
    Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M
    Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein in pancreatic endocrine neoplasms.
    Tomita T
    Mod Pathol; 2000 Apr; 13(4):389-95. PubMed ID: 10786804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic islet cell carcinoma with hypercalcemia: complete remission 5 years after surgical excision and chemotherapy.
    Bresler L; Boissel P; Conroy T; Grosdidier J
    Am J Gastroenterol; 1991 May; 86(5):635-8. PubMed ID: 1851392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue.
    Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S
    JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
    Kouvaraki MA; Ajani JA; Hoff P; Wolff R; Evans DB; Lozano R; Yao JC
    J Clin Oncol; 2004 Dec; 22(23):4762-71. PubMed ID: 15570077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pancreatic islet cell carcinoma with multiple hepatic metastases successfully treated with a streptozocin/5-FU regimen--a case report].
    Arakawa Y; Mizunuma N; Aiba K; Ito Y; Takahashi S; Irie T; Watanabe J; Tada K; Okudaira T; Seki M; Yamaguchi T; Muto T; Hatake K
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2561-4. PubMed ID: 12506483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical presentation of hormone producing cells in the pancreatic tissue of patients with hyperinsulinism].
    Függer R; Ulrich W; Krepler R; Hölbling N; Funovics J; Denk H
    Pathologe; 1982 Nov; 3(6):329-32. PubMed ID: 6296808
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of Verner-Morrison syndrome (VDHA) and its treatment with sandostatin an streptozocitin].
    Várkonyi TT; Velösy B; Nagy I; Németh J; Lonovics J
    Orv Hetil; 1993 Nov; 134(47):2599-602. PubMed ID: 8247522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responses.
    Gagel RF; Costanza ME; DeLellis RA; Norton RA; Bloom SR; Miller HH; Ucci A; Nathanson L
    Arch Intern Med; 1976 Dec; 136(12):1429-35. PubMed ID: 187136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors.
    Fjallskog ML; Janson ET; Falkmer UG; Vatn MH; Oberg KE; Eriksson BK
    Neuroendocrinology; 2008; 88(1):53-8. PubMed ID: 18285678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory diarrhea with islet cell hyperplasia and increased immunohistochemical reactivity to serotonin.
    Nishiyama RH; Thompson NW; Lloyd R; Augur NA
    Surgery; 1984 Dec; 96(6):1038-44. PubMed ID: 6095478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of metastasized pancreatic vasoactive intestinal polypeptide-secreting tumor unresponsive to high-dose octreotide by peptide receptor radionuclide therapy using 90Y DOTATATE.
    Sainz-Esteban A; Baum RP
    Clin Nucl Med; 2013 Dec; 38(12):996-7. PubMed ID: 24212444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic diarrhea of infancy: nonbeta islet cell hyperplasia.
    Ghishan FK; Soper RT; Nassif ED; Younoszai MK
    Pediatrics; 1979 Jul; 64(1):46-9. PubMed ID: 221877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
    Fahrenkrug J; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.